ITIL-306 in Advanced Solid Tumors

Similar pages

• Trial
  ITIL-168 in Advanced Solid Tumors

  Shares Instil Bio, Non-small-cell lung cancer and the tag pipeline.

• Trial
  ITIL-168 in Advanced Melanoma

  Shares Instil Bio and the tag pipeline.

• Trial
  Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment

  Shares Renal cell carcinoma, Non-small-cell lung cancer and the tag pipeline.

• Trial
  A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors

  Shares Ovarian cancer, Non-small-cell lung cancer and the tag pipeline.

• Trial
  A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

  Shares Renal cell carcinoma, Non-small-cell lung cancer and the tag pipeline.

• Trial
  A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

  Shares Ovarian cancer, Non-small-cell lung cancer and the tag pipeline.

• Trial
  Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

  Shares Renal cell carcinoma, Ovarian cancer, Non-small-cell lung cancer and the tag pipeline.

• Trial
  A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

  Shares Renal cell carcinoma, Non-small-cell lung cancer and the tag pipeline.